Compare Unichem Lab with GSK Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs GSK PHARMA - Comparison Results

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB GSK PHARMA UNICHEM LAB/
GSK PHARMA
 
P/E (TTM) x 60.6 51.5 117.7% View Chart
P/BV x 0.7 10.8 6.0% View Chart
Dividend Yield % 2.1 1.5 145.5%  

Financials

 UNICHEM LAB   GSK PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
GSK PHARMA
Mar-19
UNICHEM LAB/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs2923,595 8.1%   
Low Rs1821,253 14.5%   
Sales per share (Unadj.) Rs167.7184.7 90.8%  
Earnings per share (Unadj.) Rs-3.626.3 -13.8%  
Cash flow per share (Unadj.) Rs5.929.2 20.4%  
Dividends per share (Unadj.) Rs4.0020.00 20.0%  
Dividend yield (eoy) %1.70.8 204.6%  
Book value per share (Unadj.) Rs372.3126.3 294.7%  
Shares outstanding (eoy) m70.38169.40 41.5%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.413.1 10.8%   
Avg P/E ratio x-65.392.2 -70.8%  
P/CF ratio (eoy) x39.983.1 48.0%  
Price / Book Value ratio x0.619.2 3.3%  
Dividend payout %-110.276.1 -144.8%   
Avg Mkt Cap Rs m16,680410,626 4.1%   
No. of employees `0002.65.0 52.5%   
Total wages/salary Rs m2,3935,372 44.5%   
Avg. sales/employee Rs Th4,535.26,306.7 71.9%   
Avg. wages/employee Rs Th919.81,083.1 84.9%   
Avg. net profit/employee Rs Th-98.2898.0 -10.9%   
INCOME DATA
Net Sales Rs m11,80131,281 37.7%  
Other income Rs m9841,023 96.2%   
Total revenues Rs m12,78532,304 39.6%   
Gross profit Rs m-8356,009 -13.9%  
Depreciation Rs m674486 138.6%   
Interest Rs m756 1,253.3%   
Profit before tax Rs m-6006,540 -9.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m0287 0.0%   
Tax Rs m-3432,373 -14.5%   
Profit after tax Rs m-2564,454 -5.7%  
Gross profit margin %-7.119.2 -36.8%  
Effective tax rate %57.336.3 157.8%   
Net profit margin %-2.214.2 -15.2%  
BALANCE SHEET DATA
Current assets Rs m20,38420,061 101.6%   
Current liabilities Rs m5,02914,543 34.6%   
Net working cap to sales %130.117.6 737.6%  
Current ratio x4.11.4 293.8%  
Inventory Days Days10557 184.5%  
Debtors Days Days13514 959.3%  
Net fixed assets Rs m9,02314,343 62.9%   
Share capital Rs m1411,694 8.3%   
"Free" reserves Rs m26,05819,704 132.2%   
Net worth Rs m26,19921,398 122.4%   
Long term debt Rs m02 0.0%   
Total assets Rs m31,49639,113 80.5%  
Interest coverage x-7.01,091.0 -0.6%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.40.8 46.8%   
Return on assets %-0.611.4 -5.0%  
Return on equity %-1.020.8 -4.7%  
Return on capital %-2.031.9 -6.3%  
Exports to sales %69.40-   
Imports to sales %00-   
Exports (fob) Rs m8,188NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m8,188534 1,533.3%   
Fx outflow Rs m5967,091 8.4%   
Net fx Rs m7,592-6,557 -115.8%   
CASH FLOW
From Operations Rs m-3,2783,994 -82.1%  
From Investments Rs m-2,860-1,433 199.5%  
From Financial Activity Rs m-24-3,584 0.7%  
Net Cashflow Rs m-4,690-1,023 458.4%  

Share Holding

Indian Promoters % 50.1 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 15.1 10.2 148.0%  
FIIs % 3.0 23.8 12.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 15.4 205.8%  
Shareholders   20,176 102,036 19.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  ALEMBIC LTD  ALEMBIC PHARMA  ELDER PHARMA  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slips Over 300 Points; Axis Bank & Tech Mahindra Top Losers(12:30 pm)

Share markets in India have extended early losses and are presently trading deep in the red. Barring consumer durables sector, all sectoral indices are trading in red with stocks in the telecom sector.

Related Views on News

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

GSK PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 28.1% (Quarterly Result Update)

Jul 24, 2019 | Updated on Jul 24, 2019

For the quarter ended June 2019, GSK PHARMA has posted a net profit of Rs 1 bn (up 28.1% YoY). Sales on the other hand came in at Rs 8 bn (up 7.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

GSK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Sep 17, 2019 03:35 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS